Results 1 to 10 of about 94,409 (286)

Coronavirus Disease 2019-Associated Coagulopathy

open access: yesMicroorganisms, 2022
Coronavirus disease 2019 (COVID-19)-associated coagulopathy is an acute illness characterized by thrombosis with or without hemorrhage after COVID-19 infection.
Jun-Won Seo   +3 more
doaj   +2 more sources

Coagulopathy of Trauma [PDF]

open access: yesCritical Care Clinics, 2017
Coagulopathy is common after injury and develops independently from iatrogenic, hypothermic, and dilutional causes. Despite considerable research on the topic over the past decade, trauma-induced coagulopathy (TIC) continues to portend poor outcomes, including decreased survival.
Sabrinah Ariane Christie   +1 more
exaly   +3 more sources

Viscoelastic hemostasis assay guided diagnosis and treatment of trauma-induced coagulopathy [PDF]

open access: yesWaike lilun yu shijian, 2023
The diagnosis and treatment of trauma-induced coagulopathy is an important part of the treatment of severe trauma patients. Trauma-induced coagulopathy has two phenotypes: hypercoagulability and hypocoagulability.
SHEN Tuo, ZHU Feng
doaj   +1 more source

Understanding COVID-19-associated coagulopathy: From PIC to SIC or DIC

open access: yesJournal of Intensive Medicine, 2021
Coagulopathy, characterized by a high D-dimer level, is a common pathological occurrence in coronavirus disease 2019 (COVID-19) and is associated with poor prognosis.
Zhong Wang   +4 more
doaj   +1 more source

Traumatic Coagulopathy [PDF]

open access: yesJournal of Acute Care Surgery, 2015
Trauma patients often suffer from a “lethal triad” comprised of three entwined interacting components: hypothermia, acidosis, and coagulopathy. When the patients’ blood vessels are injured, hemostatic mechanisms are activated to heal the injured vessels ...
Joong Suck Kim, Young Hoon Sul
doaj   +1 more source

Traumatic brain injury associated coagulopathy

open access: yesLiječnički vjesnik, 2023
Traumatic brain injury associated coagulopathy is a widely recognized risk factor for secondary brain damage and a powerful predictor related to outcome and prognosis.
Petar Martinović, Jasminka Peršec
doaj   +1 more source

Footprints of coagulopathy [PDF]

open access: yesJournal of Neurology, Neurosurgery & Psychiatry, 2002
A 68 year old man with chronic atrial fibrillation and a St Jude valve in mitral position discontinued warfarin several days prior to a coronary angiogram. Forty eight hours after restarting his warfarin, while also on low molecular weight …
R D, Ecker, E F M, Wijdicks
openaire   +2 more sources

A Multicenter Retrospective Cohort Study Evaluating the Clinical Outcomes of Patients with Coagulopathy Undergoing Transcatheter Arterial Embolization (TAE) for Acute Non-Neurovascular Bleeding

open access: yesMedicina, 2023
Background and Objectives: Transcatheter arterial embolization (TAE) is the mainstay of treatment for acute major hemorrhage, even in patients with coagulopathy and spontaneous bleeding.
Roberto Minici   +16 more
doaj   +1 more source

The Many Faces of Cytokine Release Syndrome-Related Coagulopathy

open access: yesClinical Hematology International, 2021
Cytokine release syndrome (CRS) has been increasingly recognized in various conditions including the coronavirus disease 2019 (COVID-19). It is not only associated with systemic inflammatory symptoms, but also hematological complications such as ...
Jiasheng Wang, John Doran
doaj   +1 more source

Early coagulopathy after pediatric out-of-hospital cardiac arrest: secondary analysis of a randomized clinical trial

open access: yesThrombosis Journal, 2022
Background To estimate the incidence, risk factors, and impact on mortality and functional outcomes for early coagulopathy after the return of spontaneous circulation (ROSC) in pediatric out-of-hospital cardiac arrest (OHCA) patients.
Dawei Zhou   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy